A look back at the most influential drug approvals of 2005.
Explore the source record for details and available documents.
Amyloid↗
Biomedical subjects
Lynn Wimett
Publications and source records attributed to Lynn Wimett.
Duloxetine fights major depressive disorder.
Explore the source record for details and available documents.
Antidepressive Agents↗
Drug approval highlights for 2003.
In the past 12 months, the FDA has approved important new pharmaceutical drugs and devices of particular interest to primary health care providers. The drugs include: Oxytrol (for urinary incontinence), Valtrex (for reducing the risk of heterosexual transmission of genital herpes), Femring (for vaginal delivery of hormone therapy), Uroxatral (for benign prostatic hypertrophy), Levitra (for erectile dysfunction), Flumist (for preventing influenza), Xolair (for asthma), Raptiva (for psoriasis), Cubicin (for skin infections), Crestor (for hypercholesterolemia), and Coreg (for severe heart failure).
Acyclovir↗
Inspra improves survival for CHF patients.
Explore the source record for details and available documents.
Dose-Response Relationship, Drug↗
Caduet treats two cardiovascular conditions at once.
Explore the source record for details and available documents.
Amlodipine↗
Telithromycin (Ketek) for community-acquired respiratory tract infections.
Explore the source record for details and available documents.
Community-Acquired Infections↗
Oxytrol approved for overactive bladder.
Explore the source record for details and available documents.
Administration, Cutaneous↗
TNF-alpha inhibitors offer hope to RA patients.
Explore the source record for details and available documents.
Anti-Inflammatory Agents↗
First new ADHD treatment in 30 years.
Explore the source record for details and available documents.
Adolescent↗